Loading...

Anew Medical, Inc.

WENAW•NASDAQ
HealthcareBiotechnology
$0.04
$-0.00(-0.25%)

Anew Medical, Inc. (WENAW) Stock Overview

Explore Anew Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for WENAWStats details for WENAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for WENAWAnalyst Recommendations details for WENAW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

CEO

Dr. Joseph Sinkule Pharm.D.

Employees

1

Headquarters

13576 Walnut Street, Omaha, NE

Founded

1970

Frequently Asked Questions